Breastfeeding duration and asthma in Puerto Rican children

Christian Rosas-Salazar1, Erick Forno2, John M Brehm2

  • 1Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University, Nashville, Tennessee.

Pediatric Pulmonology
|August 8, 2014
PubMed

Insights

Breastfeeding for up to six months is linked to a 30% reduction in asthma odds for Puerto Rican children. Longer breastfeeding durations did not show additional asthma protection in this population.

Area of Science:

  • Pediatric Asthma Research
  • Epidemiology
  • Public Health Nutrition

Background:

  • Asthma disproportionately affects Puerto Rican children in the US.
  • Limited data exists on breastfeeding's impact on asthma within this demographic.

Purpose of the Study:

  • To investigate the association between breastfeeding duration and asthma in school-aged Puerto Rican children.
  • To evaluate if current breastfeeding recommendations align with asthma risk reduction in this population.

Main Methods:

  • A case-control study involving 1,127 Puerto Rican children aged 6-14.
  • Parental recall of breastfeeding categorized as none, 0-6 months, or >6 months.
  • Asthma defined by physician diagnosis and wheezing; logistic regression used for analysis, adjusting for multiple covariates.

Main Results:

  • Breastfeeding up to 6 months was associated with a 30% decrease in asthma odds (P=0.04).
  • Breastfeeding longer than 6 months showed no significant association with reduced asthma risk (P=0.06).

Conclusions:

  • Breastfeeding for up to 6 months is associated with lower asthma odds in Puerto Rican children.
  • Extended breastfeeding beyond 6 months did not provide additional asthma-protective benefits.
  • Findings support current recommendations for breastfeeding duration in high-risk ethnic groups.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
37
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
84